Clinical Trials
19
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (18 trials with phase data)β’ Click on a phase to view related trials
A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
- First Posted Date
- 2017-11-08
- Last Posted Date
- 2020-08-20
- Lead Sponsor
- Prothena Biosciences Limited
- Target Recruit Count
- 21
- Registration Number
- NCT03336580
- Locations
- πΊπΈ
Tufts Medical Center, Boston, Massachusetts, United States
πΊπΈMayo Clinic Minnesota, Rochester, Minnesota, United States
πΊπΈOregon Health and Science University, Portland, Oregon, United States
Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis
- First Posted Date
- 2015-12-15
- Last Posted Date
- 2018-05-04
- Lead Sponsor
- Prothena Biosciences Limited
- Target Recruit Count
- 48
- Registration Number
- NCT02630901
- Locations
- πΊπΈ
TCR Medical Corporation, San Diego, California, United States
πΊπΈUniversal Medical and Research Center, LLC, Coral Gables, Florida, United States
πΊπΈRenstar Medical Research, Ocala, Florida, United States
Single Ascending Dose Study of PRX003 in Healthy Subjects
- First Posted Date
- 2015-06-01
- Last Posted Date
- 2016-03-16
- Lead Sponsor
- Prothena Biosciences Limited
- Target Recruit Count
- 40
- Registration Number
- NCT02458677
- Locations
- πΊπΈ
Worldwide Clinical Trials Early Phase Services, San Antonio, Texas, United States
Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease
- First Posted Date
- 2014-06-06
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Prothena Biosciences Limited
- Target Recruit Count
- 64
- Registration Number
- NCT02157714
- Locations
- πΊπΈ
Collaborative Neuroscience Network, LLC, Long Beach, California, United States
πΊπΈInstitute for Neurodegenerative Disorders, New Haven, Connecticut, United States
πΊπΈParkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, United States
Single Ascending Dose Study of PRX002 in Healthy Subjects
- First Posted Date
- 2014-03-24
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- Prothena Biosciences Limited
- Target Recruit Count
- 40
- Registration Number
- NCT02095171